CSIG Interactive Session - Standard Laparoscopic Tubal Ligation vs. Bilateral Salpingectomy for Both Tubal Ligation and Cancer Prevention
Time:1:15 pm - 2:15 pm
Location:Room 1 - San Diego Convention Center
Jeffrey T. Jensen, M.D., M.P.H. (Chair), Oregon Health & Science University
Trevor Tejada Berges, M.D., Women and Infants Hospital of Rhode Island
Christopher M. Estes, M.D., M.P.H., University of Miami School of Medicine
Presented by the Contraception Special Interest Group
Standard Laparoscopic Tubal Ligation vs. Bilateral Salpingectomy for Both Tubal Ligation and Cancer Prevention: An Interactive Debate
Needs Assessment and Description
Contraception is an important and relevant topic to
members of the American Society for Reproductive
Medicine (ASRM). A review of the literature suggests that
tubectomy may reduce the risk of ovarian cancer. Since
the topic of contraception intersects with gynecology,
oncology and family planning, this live course for clinicians
in these fields will provide a highly interactive debate on
the issue of recommending tubectomy over other tubal
At the conclusion of this session, participants should be able
- Discuss the data on tubectomy and ovarian cancer
- Compare the expected surgical risks and outcomes of
laparoscopic tubectomy vs. tubal occlusion techniques
including when these are performed postpartum.
- Discuss differences between the laparoscopic and
hysteroscopic approaches to sterilization.
- Critique the literature on long-term strategies for ovarian
cancer risk reduction.
- Summarize the effects of tubectomy on ovarian function
and premature ovarian failure.
A 40-year-old nulligravid woman presents for discussion
about long-term contraception. After participating in this
session, in my practice I will tell this woman that:
- Data from well-designed randomized controlled trials
suggests that hysteroscopic tubal occlusion has a higher
effectiveness than use of a hormonal intrauterine
- Use of combined oral contraceptives increases the risk of
breast and endometrial cancer.
- The use of the levonorgestrel intrauterine system does
not increase the risk of breast cancer and lowers the risk
of endometrial cancer.
- Removal of the fallopian tubes is an effective,
permanent method of contraception with no
greater risks than standard tubal occlusion techniques
- Not applicable to my area of practice.